Dr Jeremy Grimshaw received a MBChB (MD equivalent) from the University of Edinburgh, UK. He trained as a family physician prior to undertaking a PhD in health services research at the University of Aberdeen. He moved to Canada in 2002. His research focuses on the evaluation of interventions to disseminate and implement evidence-based practice. He was the lead investigator on AFROIMPLEMENT and EU funded project that brought together European and African researchers interested to develop implementation research in sub Saharan African settings.
Dr. Grimshaw is: the Director, Clinical Epidemiology Program, Ottawa Hospital Research Institute; a Tier 1 Canada Research Chair in Health Knowledge Transfer and Uptake; and a Full Professor in the Departments of Medicine and Epidemiology and Community Medicine, University of Ottawa. He is the current co-Chair of The Cochrane Collaboration and Director of the Canadian Cochrane Network and Centre; He is the Principal Investigator of Knowledge Translation Canada (KT CANADA), an CIHR funded interdisciplinary network of nationally and internationally leading KT researchers in six Canadian academic health science centres.
Professor Isaac Kibwage graduated with a Bachelor of Pharmacy degree in 1979 from the University of Nairobi and a Masters in 1982 and acquired a Doctorate in 1985 from Katholieke Universiteit Leuven in Belgium. He joined the University of Nairobi in 1986 as a lecturer in the Department of Pharmacy, and rose to position of Professor of Pharmaceutical Chemistry in 2000. He has authored over 68 papers in Pharmaceutical Chemistry. Professor Kibwage is a Fellow of the Pharmaceutical Society of Kenya and a recipient of the Kenya Head of State Commendation on his contributions to health.
He is a Chartered Scientist and Chemist and member of Royal Society of Chemistry (U.K), New York Academy of Sciences, American Association for Advancement of the Sciences and Pharmaceutical Society of Kenya.
He has been Chairman of Department, Dean of Faculty/School of Pharmacy, and currently Principal of the College of Health Science. At the School of Pharmacy he still heads a modest research group, most of them internationally funded, engaged in research on phytomedicines. He heads the Drug Analysis and Research Unit (DARU) which offers services in development of analytical methods and consultancy in Good Pharmaceutical Manufacturing Practices. He is a consultant to a number of companies on pharmaceutical quality systems and analytical sciences.
Dr Charles Chiedza Maponga is a clinical Pharmacist who holds a Bachelor of Pharmacy Degree (B.Pharm(Hons)) from the University of Zimbabwe (UZ), a doctorate degree in Pharmacy (PharmD) from the State University of New York (SUNY-Buffalo) and a Masters in Health Professions Education (MHPE) from the University of Illinois at Chicago (UIC).
Dr. Maponga is Senior Lecturer and Director of the School of Pharmacy in the University of Zimbabwe’s College of Health Sciences (UZ-CHS) and is the Program Director for the International Pharmacotherapy Education and Research (IPERI). IPERI is an initiative of SUNY-Buffalo’s School of Pharmacy and Pharmaceutical Sciences and the UZ-School of Pharmacy which links the two institutions to advance HIV Clinical Pharmacology research.
Dr. Maponga is also a special projects advisory member to the Medicines Control Authority Zimbabwe and a member of the Pharmacists Council of Zimbabwe who chairs the Pharmacists Council’s Education and Liaison Committee.
Dr Maponga is research team member and Pharmacy Consultant for the University of Zimbabwe and University of California at San Francisco’s collaborative research program in women’s health where he provides advice on Pharmacy related issues. He has extensive training and skills in the implementation of antiretroviral medication.
Dr Maponga has been actively involved in the Adult Clinical Trials Group (ACTG)’s Pharmacology Committee and has been a protocol pharmacologist in several ACTG studies. His ACTG involvement has been partly through his linkage with the School of Pharmacy of the State University of New York at Buffalo where he holds the position of visiting International HIV Pharmacology Research Scientist.
He is co-Principal Investigator in a recently awarded NIH Fogarty International Center’s AIDS International Training and Research Program (AITRP) grant to develop HIV Clinical Pharmacology Research Programs in southern Africa.
Tina Penick Brock, RPh, MS, EdD is Professor of Clinical Pharmacy in the School of Pharmacy at the University of California, San Francisco. She received the BA in German, BS in Pharmacy and MS in Pharmaceutical Sciences from the University of Mississippi and the Doctorate of Education from the University of North Carolina at Chapel Hill. She has also completed the National Library of Medicine’s Medical Informatics Fellowship program. Dr Brock has held faculty appointments at the University of North Carolina at Chapel Hill and the University of London, where she directed an MSc in Clinical Pharmacy – International Practice and Policy.
She served as the Director of Capacity Building at Management Sciences for Health, an international NGO working to increase access to and improve use of essential medicines and health services in the developing world. She is a member of the advisory group for the WHO-UNESCO-FIP Global Pharmacy Education Taskforce and in this role, advocates for needs-based educational models and competency frameworks for all pharmaceutical cadres. Tina has worked in the United Kingdom, Germany, Japan, Indonesia, Liberia, Namibia, Kenya, Uganda, Malawi, Rwanda, Ethiopia and Tanzania.
Professor Mahama Duwiejua is a Pharmacist who has authored several pharmaceutical publications and is currently the Dean of the Faculty of Pharmacy and Pharmaceutical Sciences, College of Health Sciences, at the Kwame Nkrumah University of Science and Technology, in Kumasi, Ghana. He holds a PhD in Pharmacology and an MSc in Clinical Pharmacy. Over the last 6 years he has concentrated more on developing clinical pharmacy practice. Having helped in setting up a department of clinical pharmacy at Kwame Nkrumah University, he transferred to the department as a full time lecturer in clinical pharmacy with a reduced lecture load in pharmacology. Professor Mahama has been involved in a variety of projects like identifying pharmaceutical care needs of diabetic patients, improving adherence to medication use among patients with pulmonary tuberculosis and promoting medication safety.
Born in Moshi, Tanzania, Dr Eva Ombaka trained as a pharmacist in England where she also obtained her PhD (pharmacy) and her Masters in Public Health, and has had a chance to experience the profession from hospital practice, academia, and manufacturing. For seventeen years she was involved in issues of pharmaceutical policy development and capacity building for better pharmacy practice. Her main areas of interest are in access to and the promotion of rational use of medicines (RUM). She has been involved in several RUM and drugs and therapeutic committee (DTC) courses and was the winner of Olle Hansson award for 2007 for her work in RUM. She has participated in committees addressing different aspects of access and use of medicines in organizations such as WHO, MSH, React and HAI. In her former capacity as coordinator of Ecumenical Pharmaceutical Network and as founder and board member of Sustainable Health Care Foundation, Dr Ombaka actively supported use of available local resources, including personnel, as an effective way of learning, sharing best practices and addressing issues with understanding of local context.
Dr Hannes Enlund received an MSc and DSc in Social Pharmacy from University of Kuopio, Finland. He spent a post-doc year at Welsh School of Pharmacy, Cardiff and was appointed full professor of Social Pharmacy at University of Kuopio in 1989. He has been visiting professor at United States Pharmacopeia, Rockville and University of Maryland at Baltimore. Dr. Enlund also worked for International Narcotics Control Board, in Vienna on measuring the consumption of narcotics and psychotropic drugs. In 2000 he was appointed full professor of Pharmacy Practice at Kuwait University. In 2010 he “retired” from both professorships in Kuopio and Kuwait. In 2011 he was appointed Head of Research at Finnish Medicines Agency, Fimea. Dr. Enlund has served on the EU Advisory Committee on Pharmaceutical Training, Pharmacy Practice panel at USP, and on the Education and General Committees of the European Society of Clinical Pharmacy. He has evaluated pharmacy education and research at several European universities. Dr. Enlund has published more than 150 scientific and practice related articles on social and behavioral aspects of drug use and prescribing, polypharmacy and the elderly, hypertension treatment, patient adherence, pharmaceutical services and the role of pharmacists, drug information and patient counseling, and management of malaria.